You have successfully logged out.
B. Braun Product Security
B. Braun ensures high security standards throughout the product life cycle by using globally accepted standards. We have established processes to monitor the latest vulnerabilities, threats, or risks and will proactively implement measures as required. We have developed processes to reflect our corporate values and to uphold our responsibilities both legal and to good-faith security researchers that provide us with their expertise.
Coordinated vulnerability disclosure program
We welcome vulnerability reports from researchers, industry groups, CERTs,
partners, and any other source and will give full credit on our website once the
submission has been accepted, validated and published by our product security
Use the form provided on our webpage, or equivalent protected email data to firstname.lastname@example.org and provide us, preferably in English or German, with:
Your reference/advisory number and sufficient contact information, such as your organization and contact name so that we can get in touch with you.
A technical description of the concern or vulnerability
On which specific product you tested, including product name and version number;
The technical infrastructure was tested, including operating system and version; and any relevant additional information, such as network configuration details.
For web-based services, the date and time of testing, URLs, the browser type and version, as well as the input provided to the application.
Any additional information, including details on the tools used to conduct the testing and any relevant test configurations. If you wrote specific proof-of-concept or exploit code, please provide a copy.
If you have identified specific threats related to the vulnerability, assessed the risk, or have seen the vulnerability being exploited, please provide that information.
If you communicate vulnerability information to vulnerability coordinators such as ICS-CERT, CERT/CC, NCSC or other parties, their tracking number, if one has been made available.
A timely response to your email (within 2 business days)
After triage, we will send an expected timeline, and commit to being as transparent as possible about the remediation timeline as well as on issues or challenges that may extend it
An open dialog to discuss issues
Notification when the vulnerability analysis has completed each stage of our review
Credit after the vulnerability has been validated and fixed.
Public reporting of vulnerability in appropriate circumstances
We will not engage in legal action against individuals who submit reports through our vulnerability reporting process and enter into a legal agreement with us. We agree to work with individuals who:
Engage in testing of systems/research without harming B. Braun or its customers and certainly patients.
Adhere to the laws of their location and the location of B. Braun.
Engage in vulnerability testing within the scope of our vulnerability disclosure program in accordance with the terms and conditions of any agreements entered into between B. Braun and individuals.
Refrain from disclosing vulnerability details before any mutually agreed-upon timeframe expires.
The discloser’s actions must not be disproportionate or in bad faith, such as:
Using social engineering to gain access to the system.
Building his or her own backdoor in an information system with the intention of then using it to demonstrate the vulnerability.
Utilizing a vulnerability further than necessary to establish its existence.
Copying, modifying or deleting data on the system or making changes to it.
Repeatedly gaining access to the system or sharing access with others.
B. Braun Product Security Bulletins contains of product-specific vulnerability updates and security-related information. Our bulletins will list all known vulnerabilities for each product, the status and all recommended customer actions such as fixes or patches or other mitigation strategies. Revised bulletins are posted regularly with the latest available information.
03/2023 B. Braun Statement on Cybersecurity Vulnerability with Space Battery Pack SP with Wi-Fi
Wednesday, 15 March, 2023
11/2022 B. Braun Statement on Cybersecurity Vulnerability with OpenSSL 3.0.X
Friday, November 4, 2022
03/2022 B. Braun Statement regarding the Palo Alto Networks cybersecurity report concerning infusion devices
Friday, March 25, 2022
12/2021 B. Braun Statement on Cybersecurity Vulnerability in Apache Log4j
Tuesday, December 14, 2021
11/2021 B. Braun Statement on Cybersecurity Vulnerability with Infra:Halt
Friday, November 19, 2021
11/2021 B. Braun Statement on Cybersecurity Vulnerability with Nucleus:13
Wednesday, November 17, 2021
05/2021 SpaceCom, Battery Pack SP with WiFi, Data module compactplus - multiple vulnerabilities
Friday, May 14, 2021
04/2021: B. Braun Information concerning Name:Wreck
Monday, April 19, 2021
02/2021 OnlineSuite WiBu CodeMeter multiple vulnerabilities
Wednesday, February 24, 2021
12/2020 B. Braun Statement on Cybersecurity Vulnerability with Amnesia:33
Friday, December 18, 2020
10/2020 SpaceCom, Battery Pack SP with WiFi, Data module compactplus - multiple vulnerabilities
Monday, October 26, 2020
10/2020 Online Suite - multiple vulnerabilities
Monday, October 26, 2020